Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease
Abstract Ataxia-telangiectasia (A-T) is an autosomal recessive, multisystem disorder characterized by cerebellar degeneration, cancer predisposition, and immune system defects. A major cause of mortality in A-T patients is severe pulmonary disease; however, the underlying causes of the lung complica...
Guardado en:
Autores principales: | Rudel A. Saunders, Thomas F. Michniacki, Courtney Hames, Hilary A. Moale, Carol Wilke, Molly E. Kuo, Johnathan Nguyen, Andrea J. Hartlerode, Bethany B. Moore, JoAnn M. Sekiguchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1ed0ade54a34257bb991c94b642ee0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
por: A.J. Yeo, et al.
Publicado: (2021) -
ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer
por: Sabrina Putti, et al.
Publicado: (2021) -
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
por: Michal Smida, et al.
Publicado: (2016) -
A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation
por: Harvey Perez, et al.
Publicado: (2021) -
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.
por: Ninette Amariglio, et al.
Publicado: (2009)